Transactions
$35 Million
Lead Placement Agent
Private Placement
November 2021
Up to $160 Million
Exclusive Financial Advisor
Divestiture of Plasma-Derived Hyperimmune Product Portfolio to Kamada
November 2021
$174 Million
Bookrunner
Secondary Offering
November 2021
UNDISCLOSED
Exclusive Financial Advisor
Significant Investment in Nitel
November 2021
$3.3 Billion
Financial Advisor
Sale to Novo Nordisk
Pending
$300 Million
Joint Bookrunner
Follow-On
November 2021
UNDISCLOSED
Exclusive Financial Advisor
Acquisition of BioIQ
Pending
$500 Million
Joint Bookrunner
Follow-On
November 2021
$101 Million
Joint Bookrunner
Follow-On
November 2021
$350 Million
Joint Bookrunner
Convertible Senior Notes
November 2021
UNDISCLOSED
Financial Advisor
Significant Investment in Renaissance
Pending
$200 Million
Co-Agent
At-The-Market (ATM) Facility
November 2021
- « Previous Page
- Page 1
- Page 2
- Page 3
- ...
- Page 71
- Next Page »